Showing results (281-290 of 457) with videos related to
Sort By:
Pageof 46
Alzheimer'S Research & Therapy|November 27, 2018
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical programJeffrey L Cummings, Alireza Atri, Clive Ballard, et al.International Psychogeriatrics|July 26, 2025
Brief operationalized psychosocial interventions for agitation and psychosis: Use in clinical trials and clinical careClive Ballard, Kathryn Mills, Maria Soto, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2018
Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implicationsChristoph Mueller, Gayan Perera, Anto P Rajkumar, et al.Journal of Affective Disorders|July 10, 2002
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesClive Ballard, Mary Johnson, Margaret Piggott, et al.Alzheimer'S & Dementia (New York, N. Y.)|September 1, 2020
Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effectsYasaman Malekizadeh, Gareth Williams, Mark Kelson, et al.Dementia and Geriatric Cognitive Disorders|February 22, 2011
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's diseaseAlistair Burns, Elaine Perry, Clive Holmes, et al.Aging & Mental Health|July 14, 2015
FITS into practice: translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homesDawn J Brooker, Isabelle Latham, Simon C Evans, et al.Plos Medicine|April 4, 2008
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Clive Ballard, Marisa Margallo Lana, Megan Theodoulou, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 14, 2019
Enrichment factors for clinical trials in mild-to-moderate Alzheimer's diseaseClive Ballard, Alireza Atri, Neli Boneva, et al.The American Journal of Sports Medicine|November 19, 2020
Scapular Dyskinesis Is Not an Isolated Risk Factor for Shoulder Injury in Athletes: A Systematic Review and Meta-analysisCampbell Hogan, Jo-Anne Corbett, Simon Ashton, et al.Pageof 46